UMIN ID: UMIN000001267
Registered date:25/07/2008
Multicenter phase II trial of gemcitabine and S-1 for gallbladder cancer
Basic Information
| Recruitment status | Complete: follow-up complete |
|---|---|
| Health condition(s) or Problem(s) studied | gallbladder cancer |
| Date of first enrollment | 2008/04/01 |
| Target sample size | 20 |
| Countries of recruitment | Japan |
| Study type | Interventional |
| Intervention(s) | anti-cancer drug |
Outcome(s)
| Primary Outcome | efficacy |
|---|---|
| Secondary Outcome |
Key inclusion & exclusion criteria
| Age minimum | 20years-old |
|---|---|
| Age maximum | 75years-old |
| Gender | Male and Female |
| Include criteria | |
| Exclude criteria | The exclusion criteria are as follows: active infection. pregnant or lactating women, women of childbearging age. the patient inappropriate for entry onto this study in the judgment of the investigator. |
Related Information
| Primary Sponsor | Nagoya University Hospital |
|---|---|
| Secondary Sponsor | |
| Source(s) of Monetary Support | Nagoya University Graduate School of Medicine |
| Secondary ID(s) |
Contact
| public contact | |
| Name | Yoshiki Hirooka |
| Address | Japan |
| Telephone | 052-744-2602 |
| Affiliation | Nagoya University Hospital Department of Endoscopy |
| scientific contact | |
| Name | Yoshiki Hirooka |
| Address | 65,Tsuruma-Cho,Showa-Ku,Nagoya City Japan |
| Telephone | 052-744-2602 |
| Affiliation | Nagoya University Hospital Department of Endoscopy |